Oakstone Comprehensive Review of Psychiatry 2026 (Videos)

Comprehensive Psychiatry Board Review & Clinical Update | DSM-5, Psychopharmacology, Psychotherapy, AI in Psychiatry & Modern Mental Health Care

Advance your psychiatric knowledge with Oakstone Comprehensive Review of Psychiatry 2026, a comprehensive online continuing medical education (CME) program that delivers an evidence-based review of the full spectrum of clinical psychiatry. Designed for board preparation and daily clinical practice, this expert-led course features more than 50 guideline-driven lectures covering psychiatric diagnosis, pharmacologic and psychotherapeutic management, emerging therapies, and evolving trends in mental healthcare.

Released on July 31, 2026, this program provides psychiatrists and psychiatry residents with practical strategies to improve diagnostic accuracy, personalize treatment plans, and remain current with rapidly evolving psychiatric practice.

Product Details

• Course: Oakstone Comprehensive Review of Psychiatry 2026
• Provider: Oakstone
• Original Release: July 31, 2026
• Format: Videos
• Language: English
• Educational Level: Intermediate to Advanced
• Learning Format: Expert Lectures, Case-Based Learning, Guideline-Based Reviews

Course Overview

Modern psychiatry continues to evolve through advances in neuroscience, psychopharmacology, psychotherapy, digital health, and precision medicine. Clinicians must remain current with DSM-5 diagnostic criteria, evidence-based treatment strategies, and emerging therapies while managing increasingly complex psychiatric presentations across inpatient and outpatient settings.

Comprehensive Review of Psychiatry 2026 provides an in-depth review of major psychiatric disorders, including mood disorders, psychotic disorders, anxiety disorders, personality disorders, trauma-related disorders, and neurocognitive conditions. The curriculum integrates current psychopharmacology, psychotherapy, treatment-resistant illness, collaborative care models, and new developments such as artificial intelligence, psychedelic-assisted therapies, GLP-1 receptor agonists, and the influence of social media on mental health.

Designed for board preparation and clinical practice, this course combines practical guidance with the latest evidence to help clinicians deliver personalized, patient-centered psychiatric care.

What You’ll Learn

After completing this course, participants will be able to:

• Diagnose major psychiatric disorders using current DSM-5 criteria.
• Differentiate psychotic, mood, anxiety, personality, trauma-related, and neurocognitive disorders.
• Select evidence-based pharmacologic and psychotherapeutic treatments.
• Optimize management of treatment-resistant psychiatric illness.
• Integrate psychiatric care into multidisciplinary medical settings.
• Apply emerging evidence involving AI, psychedelic therapies, and metabolic interventions in psychiatry.
• Personalize treatment plans for complex psychiatric patients.

Comprehensive Topics Covered

Mood Disorders

Master evidence-based mood disorder management.

Topics include:

• Major depressive disorder
• Bipolar disorder
• Mood stabilizers
• Depression management
• Treatment-resistant depression
• Suicide risk assessment
• Clinical decision-making

Psychotic Disorders

Improve diagnosis and treatment.

Topics include:

• Schizophrenia
• Psychosis
• First-episode psychosis
• Differential diagnosis
• Antipsychotic medications
• Long-term management
• Functional recovery

Anxiety Disorders

Strengthen anxiety disorder management.

Topics include:

• Generalized anxiety disorder
• Panic disorder
• Social anxiety disorder
• Obsessive-compulsive spectrum
• Evidence-based therapy
• Medication management
• Psychotherapy

Personality Disorders

Develop practical diagnostic skills.

Topics include:

• DSM-5 personality disorders
• Behavioral assessment
• Differential diagnosis
• Clinical management
• Therapeutic approaches
• Longitudinal care
• Patient-centered treatment

Trauma & Stress-Related Disorders

Enhance trauma-informed psychiatric care.

Topics include:

• PTSD
• Acute stress disorder
• Dissociation
• Trauma-related disorders
• Psychological trauma
• Recovery strategies
• Clinical assessment

Neurocognitive Disorders

Recognize cognitive and behavioral syndromes.

Topics include:

• Dementia
• Mild cognitive impairment
• Neurocognitive disorders
• Behavioral symptoms
• Diagnostic evaluation
• Clinical management
• Cognitive assessment

Psychopharmacology

Update medication management strategies.

Topics include:

• Antidepressants
• Mood stabilizers
• Antipsychotics
• Medication selection
• Treatment-resistant illness
• Precision prescribing
• Medication safety

Psychotherapy

Integrate evidence-based psychological treatments.

Topics include:

• Individual psychotherapy
• Couples therapy
• Family therapy
• Positive psychiatry
• Collaborative care
• Behavioral interventions
• Patient engagement

Emerging Topics in Psychiatry

Explore future directions in mental healthcare.

Topics include:

• Artificial intelligence
• AI in psychiatry
• Psychedelic therapies
• GLP-1 receptor agonists
• Digital psychiatry
• Social media and mental health
• Precision psychiatry

Integrated & Complex Psychiatric Care

Manage medically complex patients.

Topics include:

• Consultation-liaison psychiatry
• Integrated psychiatric care
• Medical-psychiatric collaboration
• Inpatient psychiatry
• Outpatient psychiatry
• Complex psychiatric illness
• Multidisciplinary care

Learning Objectives

Upon completion of this educational activity, participants will be able to:

• Define dissociation in the context of patient presentation.
• Describe current models for integrating psychiatric and medical care.
• Differentiate available mood stabilizers and understand their appropriate clinical use.
• Summarize the role of couples therapy and family therapy in psychiatric practice.
• Identify strategies that promote well-being within positive psychiatry.
• Distinguish schizophrenia from psychosis based on clinical presentation.
• Recognize behavioral features that define personality disorders.
• Identify trauma-related disorders according to DSM-5 diagnostic criteria.

Educational Highlights

• Psychiatry
• DSM-5
• Mood Disorders
• Depression
• Bipolar Disorder
• Schizophrenia
• Psychosis
• Anxiety Disorders
• Personality Disorders
• PTSD
• Dissociation
• Neurocognitive Disorders
• Psychopharmacology
• Psychotherapy
• Family Therapy
• Positive Psychiatry
• Artificial Intelligence
• Psychedelic Therapy
• GLP-1 Receptor Agonists
• Social Media & Mental Health
• Integrated Psychiatry
• Board Review
• Continuing Medical Education (CME)

Why This Course Stands Out

Oakstone Comprehensive Review of Psychiatry 2026 delivers a balanced combination of board-focused education and practical clinical updates. Beyond comprehensive coverage of core psychiatric disorders and evidence-based treatments, the course explores emerging innovations such as AI-assisted psychiatry, psychedelic therapeutics, metabolic interventions, and collaborative care models, preparing clinicians for the future of psychiatric practice.

Target Audience

This educational activity is ideal for:

• Psychiatrists
• Psychiatry Residents
• Psychiatry Fellows
• Consultation-Liaison Psychiatrists
• Academic Psychiatrists
• Behavioral Health Physicians
• Mental Health Clinicians preparing for board certification or recertification

Why Choose This Course?

Whether you are preparing for psychiatry board examinations, updating your clinical knowledge, or seeking practical guidance for managing complex psychiatric disorders, Oakstone Comprehensive Review of Psychiatry 2026 provides a comprehensive, evidence-based educational experience. Through expert-led lectures and guideline-driven instruction, participants gain practical skills that improve diagnostic confidence, treatment selection, and long-term patient care.

+ Topics:

Approach to the Patient

• Screening, Evaluation, and Diagnosis – Antoine Douaihy, MD

Psychiatric Disorders

• Schizophrenia and Other Psychotic Disorders – Sanya Virani, MD, MPH, FAPA
• Depressive and Bipolar Disorders in Adults – Madeleine R. Lepore, DNP
• Bipolar and Related Disorders in Youth – Rasim Somer Diler, MD, DFAACAP
• Anxiety Disorders – Thersilla Oberbarnscheidt, MD, PhD
• Obsessive Compulsive and Related Disorders – Robert Hudak, MD
• Trauma And Stressor-Related Disorders – Brigitte Khoury, PhD
• Personality Disorders – Vint Blackburn, MD
• Dissociative Disorders – Pamela R. Fuller, PhD
• Major Neurocognitive Disorders – Rita Khoury, MD
• Psychiatric Emergencies – Varad Deshmukh, MD
• Feeding and Eating Disorders – Tala Abdallah, DClinPsy
• Somatic Symptoms and Related Disorders – Soumitra Das, MD
• Sleep Medicine for the Psychiatrist – Shizuka Tomatsu, MD
• Suicide Epidemiology and Risk Assessment – Nadine Melhem, PhD
• Substance-Related Disorders – Antoine Douaihy, MD
• Violence and Psychiatry – Stephanie Rolin, MD
• Gambling Disorder – Kavita Fischer, MD
• Reproductive Psychiatry – Jody Glance, MD
• Psychiatric Manifestations of Common Medical Conditions – Daniel Salahuddin, MD
• Psychiatric Aspects of HIV and HCV – Jordi Blanch, MD
• Chronic Pain for the Psychiatrist – A Clinical Update – Xavier Jimenez, MD
• Intellectual Disabilities – Antonio Hardan, MD
• Attention Deficit Hyperactivity Disorder Across the Lifespan – Children, Adolescents, and Adults – Fadi Maalouf, MD, PhD
• Anxiety and Mood Disorders in Children and Adolescents – Fadi Maalouf, MD, PhD
• Psychiatric Issues in the LGBTQIA+ Population – Cultivating Resilience, Health, and Emotional Wellbeing – Antoine Douaihy, MD
• Psychiatric Genetics – Ilya Blokhin, MD, PhD

Treatments: Psychopharmacology

• Antidepressants and Mood Stabilizers – Megha Patel, PharmD, BCPS
• Antipsychotics – A Case Based Approach – K.N. Roy Chengappa, MD
• Anxiolytics and Sedative-Hypnotic Agents – Tanya Fabian, PharmD, PhD
• Psychopharmacological Treatments of Substance Use Disorders (SUDs) – Antoine Douaihy, MD
• Pharmacological Treatments of Attention Deficit Hyperactivity Disorder – Rebecca Miller, MD
• Treatment of Major Neurocognitive Disorders – Rita Khoury, MD

Treatments: Psychotherapy

• Cognitive Behavioral Therapy – Jennifer E. Wildes, PhD
• Dialectical Behavior Therapy – Stephanie Stepp, PhD
• Social Rhythm Therapy – Holly Swartz, MD
• Motivational Interviewing – Antoine Douaihy, MD
• Couples and Family Therapy – Jay Lebow, PhD
• Positive Psychiatry – Dennis C. Daley, PhD

Other Treatments

• Management of Treatment-Resistant Depression – Matt Conlon, MD
• Update on Electroconvulsive Therapy – LalithKumar Solai, MD
• Psychedelic Compounds in Psychiatry – Novel Treatment Paradigms in Mental Health – Danilo De Gregorio, PharmD, PhD
• Medicinal Cannabis – Antoine Douaihy, MD
• Special Topics
• Integrating Medical and Psychiatric Care – Alex Israel, MD
• Telepsychiatry – Potential and Challenges – Robert Tessier, MD
• Palliative Care Psychiatry – Elizabeth Hale, MD
• Climate Change and Mental Health – Antoine Douaihy, MD
• GLP-1 Receptor Agonists and Psychiatric illness – Antoine Douaihy, MD
• Artificial Intelligence and Psychiatry – Shiri Sadeh-Sharvit, MD
• The Impact of Social Media Use on Mental Health – Candice Biernesser, MD
• Mindfulness-Based Interventions and Psychiatric Disorders – Antoine Douaihy, MD
• Legal and Ethical Issues in the Practice of Psychiatry – Sanya Virani, MD, MPH, FAPA
• Competency and Capacity in Clinical Practice – Elias Ghossoub, MD